lilly glp-1 pill The FDA approved a new from Eli on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Watch Lilly's GLP-1 Pill Outperforms

PlexusDx uses data from these landmark studies to inform dosing protocols that maximize individual response

10.1093/ajcn/nqab262 Am J Clin Nutr

The degree of weight loss we are seeing could potentially reduce the need for bariatric surgery in many patients, while the metabolic improvements suggest we might be able to induce diabetes remission more consistently than ever before

Over time, insulin resistance contributes to the development of obesity, diabetes and cardiovascular diseases, and sustained hyperinsulinemia contributes to the generation and/or maintenance of ovulatory dysfunction (175, 176)

The budget for direct-to-consumer advertising is massive, and that cost is ultimately passed on to patients

doi: 10.1089/met.2010.0025 57 IepsenEWTorekovSSHolstJJ